Results 121 to 130 of about 60,298 (290)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Psoriasis and vitiligo are close relatives
Clinical, Cosmetic and Investigational Dermatology, 2017 Khalifa E Sharquie,1 Husam Ali Salman,1 Aseel K Yaseen2 1Department of Dermatology and Venereology, College of Medicine, University of Baghdad, Baghdad, Iraq, 2Department of Dermatology and Venereology, Baghdad Teaching Hospital, Baghdad, Iraq Background:
Sharquie KE, Salman HA, Yaseen AK
doaj
Indian Journal of Dermatology, 2018 There are very few published studies in the literature examining the association between vitiligo and skin cancers and only some anecdotal reports about phototherapy-associated nonmelanoma skin carcinoma (NMSC) in patients with vitiligo.
Xiao Ting Zhang +4 more
doaj +1 more source
Implementation of an Ultraviolet Phototherapy Service at a National Referral Hospital in Western Kenya: Reflections on Challenges and Lessons Learned. [PDF]
, 2020 IntroductionIn order to manage skin conditions at a national referral hospital level in Kenya, specialized dermatology services, such as dermatologic surgery, dermatopathology, phototherapy, and sub-specialty care, should be offered, as is typically ...
Beck, Kristen +17 more
core
1188 Disorganization of basement membrane zone architecture for impaired melanocyte inhabitation in vitiligo [PDF]
, 2023 F. Yang +11 more
openalex +1 more source
Vitiligo Arising at the Injection Site of Interferon‐α
JEADV Clinical Practice, EarlyView.
Yubin Peng, Tao Wang
wiley +1 more source
Well‐being in German patients with vitiligo in genital and visible areas – a pilot study
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background Only a few studies exist on the psychosocial impact of vitiligo in German patients, in particular those affected in genital and visible body areas. Methods This monocentric pilot study aimed to assess well‐being of adult patients with vitiligo and to compare sex, age, and clinical characteristics between patients with and without ...
Janne Ohlenbusch +3 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Hair loss disorders impact quality of life (QoL) far beyond cosmetic issues, with previous studies showing mild to moderate impairment. This study aimed to assess QoL impairment in hair loss patients, comparing scarring and non‐scarring alopecia, and to analyze possibly related influencing factors.
Agathe Franz +7 more
wiley +1 more source
Anais Brasileiros de Dermatologia, 2011 FUNDAMENTO: O vitiligo é considerado a hipomelanose adquirida mais frequente. Apesar de sua etiopatogenia ser incerta, acredita-se que a etiologia autoimune seja a mais plausível, teoria que se fundamenta na concomitância de vitiligo com doenças ...
Daniel Holthausen Nunes +1 more
doaj +1 more source
International Journal of Cosmetic Science, EarlyView.Natural antioxidants from plants, fruits, seeds and fungi combat ageing by neutralizing free radicals, boosting collagen and protecting against UV damage. Enhanced by green extraction and smart delivery systems, they offer powerful anti‐inflammatory and antimicrobial benefits.
Hossein Omidian +2 more
wiley +1 more source